Measurement of endothelium-dependent vasodilation in mice-brief report

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 12, 2014, Pages 2651-2657

  Schuler, Dominik ^a   Sansone, Roberto ^a   Freudenberger, Till ^b   Rodriguez Mateos, Ana ^a   Weber, Gesine ^a   Momma, Tony Y ^a,e   Goy, Christine ^d   Altschmied, Joachim ^d   Haendeler, Judith ^c,d   Fischer, Jens W ^b   Kelm, Malte ^a   Heiss, Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Institute for Pharmacology Clinical Pharmacology   (United States)

^c Laboratory of Medicine   (Germany)

^d IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Blood flow velocity; Doppler duplex ultrasonography; Endothelial nitric oxide synthase; Femoral artery; Flavonoids; vasodilation

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) NITROARGININE METHYL ESTER; ENZYME INHIBITOR; NOS3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTERIAL STIFFNESS; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; CORE TEMPERATURE; DIGITAL IMAGING; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; FEMORAL ARTERY; FLOW MEDIATED VASODILATION; FLOW RATE; HEART RATE; HUMAN; MEASUREMENT; MOUSE; NONHUMAN; NORMAL HUMAN; PULSE WAVE; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; GENETICS; HINDLIMB; HYPEREMIA; ISCHEMIA; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMORAL ARTERY; HINDLIMB; HUMANS; HYPEREMIA; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; VASODILATION;

EID: 84918827482     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304699     Document Type: Article

References (12)

1. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis. Int J Cardiol. 2012;168:344-351.
2. Wang C.H., Chen KT, Mei HF, Lee JF, Cherng WJ, Lin SJ. Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses. J Vasc Surg. 2011;53:1350-1358.
3. Kelm M. Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects. Am J Physiol Heart Circ Physiol. 2002;282:H1-H5.
4. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension. 2011;57:363-369.
5. Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23:374-380.
6. Moncada S, Higgs EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet. 1977;1:18-20.
7. Sidney S, Rosamond WD, Howard VJ, Luepker RV; National Forum for Heart Disease and Stroke Prevention. The "heart disease and stroke statistics-2013 update" and the need for a national cardiovascular surveillance system. Circulation. 2013;127:21-23.
8. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441-1448.
9. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord. 2002;26:754-764.
10. Meir KS, Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol. 2004;24:1006-1014.
11. Heiss C, Keen CL, Kelm M. Flavanols and cardiovascular disease prevention. Eur Heart J. 2010;31:2583-2592.
12. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (?)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024-1029.